Advancements in Multi-Cancer Early Detection (MCED) Tests Driving Explosive Growth in Liquid Biopsy Industry
The advent of multi-cancer early detection (MCED) tests has catapulted the liquid biopsy market into the spotlight, offering a paradigm shift in how cancer is detected. Unlike single-cancer screening tools, MCED tests analyze a panel of biomarkers—such as circulating tumor DNA (ctDNA), proteins, and methylation patterns—to identify multiple cancer types from a single blood sample....
0 Bình luận
0 Chia sẻ
208 Lượt xem
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)